GinkoPrim® Max 100 mg (Paziņots 2011.)
Food supplement registered in Latvia
Register snapshot dated 2 May 2025. It does not establish the current status of the product.
- Number published by PVD
- 0000179/2012
- Type
- Food supplement
- Published status
- Status not provided in this export; the validity date is shown separately
- Licence holder
- Walmark, SIA
- Manufacturer
- Walmark,a.s.
- Origin
- Latvija
- Register snapshot
- 2 May 2025
- Recommended daily intake (Latvian text)
- 1 tablete dienā pēc ēšanas, uzdzerot ūdeni
- Published pack size
- tabletes pa 950 mg
- Published packaging
- 30, 60 vai 90 tabletes iepakojumā
This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
The foreign register category does not determine the regulatory category of the product in France.
Published composition
| Published name | Published text and quantity | Recognised ingredient | Role or context |
|---|---|---|---|
| Magnijs | minerals ; Magnijs ; 150 ; mg | Magnésium | Vitamin or mineral |
| Divdaivu ginka lapu standartizēts ekstrakts (satur flavonglikozīdus 24%, terpenolaktonus 6%) | plants ; Divdaivu ginka lapu standartizēts ekstrakts (satur flavonglikozīdus 24%, terpenolaktonus 6%) ; Ginkgo biloba ; 100 ; mg | ginkgo biloba | Plant |
| Mikrokristāliskā celuloze (E460) | otherIngredients ; Mikrokristāliskā celuloze (E460) | Listed as food additive E 460(i) (EU Union list) | Role not identified |
| Hidroksipropilmetilceluloze (E464) | otherIngredients ; Hidroksipropilmetilceluloze (E464) | Listed as food additive E 464 (EU Union list) | Role not identified |
| Glicerīns (E422) | otherIngredients ; Glicerīns (E422) | Listed as food additive E 422 (EU Union list) | Role not identified |
| Titāna dioksīds (E171) | otherIngredients ; Titāna dioksīds (E171) | Not recognised | Role not identified |
| Riboflavīns (E101) | otherIngredients ; Riboflavīns (E101) | Vitamine B2 (riboflavine) | Vitamin or mineral |
| Indigokarmīns (E132) | otherIngredients ; Indigokarmīns (E132) | Listed as food additive E 132 (EU Union list) | Role not identified |
| Briljantzilais FCF (E133) | otherIngredients ; Briljantzilais FCF (E133) | Listed as food additive E 133 (EU Union list) | Role not identified |
| Saflora koncentrāts | otherIngredients ; Saflora koncentrāts | Not recognised | Role not identified |
| Taukskābju magnija sāļi (E470b) | otherIngredients ; Taukskābju magnija sāļi (E470b) | Listed as food additive E 470b (EU Union list) | Role not identified |
| Triglicerīdu eļļa | otherIngredients ; Triglicerīdu eļļa | Not recognised | Role not identified |
Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.
Manufacturer countries
Čehija
French and European references for recognised ingredients
- À vérifier
The composition lists additive E171 (titanium dioxide), removed from the list of additives allowed in food, supplements included: since 7 August 2022, a supplement containing it can no longer be placed on the market in the Union.
règlement (UE) 2022/63. Regulation (EU) 2022/63: titanium dioxide (E171) removed from the food additives allowed in the EU, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Information
Amount read: 150 mg. Daily basis unknown: no comparison with daily reference values.
PVD, Latvian food supplement register, retrieved 28 October 2026.
PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.
- Information
French reference: maximum dose of 300 mg a day (Order of 9 May 2006, not revised since November 2006).
French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Information
EFSAEuropean Food Safety Authority. reference for adults: 250 mg a day, food included (safety limit).
EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Information
Amount read: 100 mg. Daily basis unknown: no comparison with daily reference values.
PVD, Latvian food supplement register, retrieved 28 October 2026.
PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.
- Information
ginkgo biloba is on the list of plants allowed in food supplements (Order of 24 June 2014). Restriction: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Information
Dose not read: compare the one on the label with the references on the nutrient’s page.
PVD, Latvian food supplement register, retrieved 28 October 2026.
PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.
Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.
Official source
Internet Archive copy dated 3 May 2025
PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Divdaivu ginka lapu standartizēts ekstrakts (satur flavonglikozīdus 24%, terpenolaktonus 6%)
Read the warning, when it applies and the studies cited
GINKGO - GINKGO BILOBA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).
Sources cited by Health Canada (3)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
- WHO 1999: World Health Organization. WHO monographs on selected medicinal plants, Volume 1. Geneva (CHE): World Health Organization; 1999.
- OMS 1999 : Organisation mondiale de la santé (OMS). Monographs on selected medicinal plants, Volume 1. Genève (CHE): Organisation mondiale de la santé; 1999.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).
Sources cited by Health Canada (1)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Contraindications
Do not use if you are having a surgery (Gardner and McGuffin 2013).
Sources cited by Health Canada (1)
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.
Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).
Sources cited by Health Canada (3)
- Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. Journal of General Internal Medicine 2005;20(7):657-661. PubMed Systematic review
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “GinkoPrim® Max 100 mg (Paziņots 2011.)”, https://compoatlas.com/en/supplements/latvia/3458-ginkoprim-max-100-mg-pazinots-2011, updated 28 October 2026.